Fate Therapeutics Inc (NASDAQ:FATE)

Delayed Data
As of 4:00pm ET
 +3.22 / +6.22%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 18 analysts offering 12-month price forecasts for Fate Therapeutics Inc have a median target of 110.50, with a high estimate of 145.00 and a low estimate of 60.00. The median estimate represents a +100.91% increase from the last price of 55.00.

Analyst Recommendations

The current consensus among 18 polled investment analysts is to Buy stock in Fate Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -49.11%
Growthannually -5.18%


Growthquarterly -22.32%
Growthannually 59.32%
Key to the earnings and sales forecast charts.